Related Experiment Video
Updated: Apr 16, 2026

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
Published on: August 2, 2024
C-terminal domain of SMYD3 serves as a unique HSP90-regulated motif in oncogenesis
Mark A Brown1, Kenneth Foreman2, June Harriss3
1Department of Clinical Sciences, Colorado State University, Fort Collins, CO 80523, USA.
Abstract:
The SMYD3 histone methyl transferase (HMTase) and the nuclear chaperone, HSP90, have been independently implicated as proto-oncogenes in several human malignancies. We show that a degenerate tetratricopeptide repeat (TPR)-like domain encoded in the SMYD3 C-terminal domain (CTD) mediates physical interaction with HSP90. We further demonstrate that the CTD of SMYD3 is essential for its basal HMTase activity and that the TPR-like structure is required for HSP90-enhanced enzyme activity. Loss of SMYD3-HSP90 interaction leads to SMYD3 mislocalization within the nucleus, thereby losing its chromatin association. This results in reduction of SMYD3-mediated cell proliferation and, potentially, impairment of SMYD3's oncogenic activity. These results suggest a novel approach for blocking HSP90-driven malignancy in SMYD3-overexpressing cells with a reduced toxicity profile over current HSP90 inhibitors.
Insights
The SMYD3 histone methyl transferase (HMTase) interacts with HSP90, a nuclear chaperone. This interaction is crucial for SMYD3
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- SMYD3 histone methyl transferase (HMTase) and HSP90 are proto-oncogenes.
- Their roles in human malignancies are independently established.
Purpose of the Study:
- To investigate the interaction between SMYD3 and HSP90.
- To elucidate the functional consequences of this interaction on SMYD3 activity and oncogenic potential.
Main Methods:
- Co-immunoprecipitation assays to confirm physical interaction.
- Site-directed mutagenesis to identify critical domains.
- Cellular localization studies using microscopy.
- Assessment of HMTase activity and cell proliferation assays.
Main Results:
- A tetratricopeptide repeat (TPR)-like domain in SMYD3's C-terminal domain (CTD) mediates HSP90 binding.
- SMYD3's CTD is essential for basal HMTase activity; the TPR-like structure is required for HSP90-enhanced activity.
- Disruption of the SMYD3-HSP90 interaction causes SMYD3 mislocalization, loss of chromatin association, reduced cell proliferation, and potentially impaired oncogenic activity.
Conclusions:
- The SMYD3-HSP90 interaction is critical for SMYD3's function and oncogenic activity.
- Targeting this interaction offers a novel therapeutic strategy for SMYD3-overexpressing cancers.
- This approach may provide a reduced toxicity profile compared to current HSP90 inhibitors.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
Abnormal Proliferation
TGF - β Signaling Pathway
Induced Pluripotent Stem Cells
Somatic...
Hedgehog Signaling Pathway

